Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

France Issues EU’s First Cybersecurity Guidelines

  • Post author:Sam
  • Post published:August 15, 2019
  • Post category:The GMP Letter

France’s National Agency for Safety of Medicines and Health Products released new cybersecurity recommendations for medical devices designed to minimize the risk of cyber attacks. Source: The GMP Letter

Continue ReadingFrance Issues EU’s First Cybersecurity Guidelines

Canada Issues New Premarket Requirements for Cybersecurity

  • Post author:Sam
  • Post published:August 15, 2019
  • Post category:The GMP Letter

Health Canada has issued new guidance on its premarket requirements for medical device cybersecurity. Source: The GMP Letter

Continue ReadingCanada Issues New Premarket Requirements for Cybersecurity

FDA Warns of Security Holes in Medtronic’s Insulin Pumps

  • Post author:Sam
  • Post published:August 15, 2019
  • Post category:The GMP Letter

Certain models of Medtronic’s MiniMed insulin pumps have potential cybersecurity risks and should be swapped out for newer models, the FDA advised. Source: The GMP Letter

Continue ReadingFDA Warns of Security Holes in Medtronic’s Insulin Pumps

483 Roundup: FDA Cites Five Firms for Complaints, Validations

  • Post author:Sam
  • Post published:August 15, 2019
  • Post category:The GMP Letter

The FDA rapped five devicemakers for a variety of violations including complaint handling, validations and failure to establish procedures for process changes. Source: The GMP Letter

Continue Reading483 Roundup: FDA Cites Five Firms for Complaints, Validations

FDA Issues Draft Guidance on Labeling of Combination Products

  • Post author:Sam
  • Post published:August 15, 2019
  • Post category:The GMP Letter

The FDA released draft guidance on the content and formatting of Instructions for Use (IFU) for drug- or biologic-device combinations. Source: The GMP Letter

Continue ReadingFDA Issues Draft Guidance on Labeling of Combination Products

Industry Supports Reclassification of Surgical Staplers, But Adds Caution

  • Post author:Sam
  • Post published:August 15, 2019
  • Post category:The GMP Letter

Most comments on the FDA’s draft guidance for reclassifying surgical staplers supported the move to reclassify devices from Class I to Class II but some cautioned that the rule could…

Continue ReadingIndustry Supports Reclassification of Surgical Staplers, But Adds Caution

FDA Warns Clinicon for Lax Testing, Validation of Sterilization Processes

  • Post author:Sam
  • Post published:August 15, 2019
  • Post category:The GMP Letter

The FDA issued a June 20 warning letter to Clinicon for quality system lapses related to its SureProble Class II sterile probe following an April 3-4 inspection of the firm’s…

Continue ReadingFDA Warns Clinicon for Lax Testing, Validation of Sterilization Processes

FDA Finalizes Guidance on Postmarketing Safety Reporting for Combination Products

  • Post author:Sam
  • Post published:August 15, 2019
  • Post category:The GMP Letter

The FDA has issued a final guidance on postmarketing safety reporting (PMSR) requirements for combination products. Source: The GMP Letter

Continue ReadingFDA Finalizes Guidance on Postmarketing Safety Reporting for Combination Products

U.S. Urges EU to Delay Implementing EU MDR/IVDR by Three Years

  • Post author:Sam
  • Post published:August 15, 2019
  • Post category:The GMP Letter

With only nine months to go before the EU’s Medical Device Regulation hits its May 26 application date, the U.S. is pressing the EU to delay implementation for another three…

Continue ReadingU.S. Urges EU to Delay Implementing EU MDR/IVDR by Three Years

FDA Releases Recommendations on Using the Inactive Ingredient Database

  • Post author:Sam
  • Post published:August 13, 2019
  • Post category:Drug GMP Report

The FDA issued draft recommendations for drug developers on how to make the best use of the agency’s online database of inactive ingredients. Source: Drug GMP Report

Continue ReadingFDA Releases Recommendations on Using the Inactive Ingredient Database
  • Go to the previous page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.